Fig. 1From: The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysisPRISMA flow diagramFrom: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA gropu (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLos Med 6(6): e1000097. https://doi.org/10.1371/journal.pmed1000097For more information, visit https://www.prisma-statement.orgBack to article page